Onderneming Medicenna Therapeutics Corp.
Aandelen
MDNA
CA58490H1073
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,38 CAD | +3,03% | +22,05% | +466,67% |
Vakgebied
Aantal werknemers: 16
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 01-10-11 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 02-02-15 |
David Hyman
DFI | Director of Finance/CFO | - | 14/02 |
Delphine Davan
IRC | Investor Relations Contact | - | 14-08-23 |
Minh To
PRN | Corporate Officer/Principal | - | 14-08-23 |
Eamonn Peters
PRN | Corporate Officer/Principal | - | 14-08-23 |
Evelyn Pau
PRN | Corporate Officer/Principal | - | 14-08-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 24-09-19 |
Albert Beraldo
BRD | Director/Board Member | - | 22-11-16 |
Fahar Merchant
CEO | Chief Executive Officer | - | 02-02-15 |
Founder | - | 01-10-11 | |
Jack Geltosky
BRD | Director/Board Member | 78 | 30-09-20 |
John Sampson
BRD | Director/Board Member | - | 23-09-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 74 778 857 | 48 558 694 ( 64,94 %) | 0 | 64,94 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+466,67% | 121 mln. | |
+26,28% | 48,09 mld. | |
-3,99% | 40,43 mld. | |
+45,32% | 40,62 mld. | |
-6,20% | 28,36 mld. | |
+6,36% | 24,89 mld. | |
-21,47% | 19,01 mld. | |
+27,58% | 12,09 mld. | |
-2,75% | 11,8 mld. | |
-2,02% | 11,88 mld. |
- Beurs
- Aandelen
- Koers MDNA
- Onderneming Medicenna Therapeutics Corp.